Voyager Therapeutics Inc (VYGR) — Cash Flow Reinvestment Rate
Voyager Therapeutics Inc (VYGR) has a Cash Flow Reinvestment Rate of 1.67x as of March 2024, reinvesting $98.21 Million (capex $2.14 Million plus investments $-96.06 Million) from operating cash flow of $58.77 Million. Check Voyager Therapeutics Inc (VYGR) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Voyager Therapeutics Inc Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Voyager Therapeutics Inc across 3 annual periods. Explore VYGR long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Voyager Therapeutics Inc (2015–2023)
Year-by-year capital reinvestment analysis for Voyager Therapeutics Inc. For live market cap and broader valuation context, see Voyager Therapeutics Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.86x | $144.90 Million | $77.92 Million | $3.26 Million | ▼ -0.2% |
| 2019 | 1.86x | $90.65 Million | $48.67 Million | $7.72 Million | ▼ -60.5% |
| 2015 | 4.72x | $194.77 Million | $41.30 Million | $1.03 Million | — |